DOT To Include Mandatory Expanded Opioids Testing for Safety Sensitive Employees
December 01, 2017
The test requirement will be known as a five panel with expanded opioids. Additionally, this change will add MDA as an initial test analyte and remove MDEA as a confirmatory test analyte.
At this time, urinalysis will remain as the only approved method for Department of Transportation drug test panels. The revision brings DOT regulations into harmony with the U.S. Department of Health and Human Services (HHS) regulations which went into effect on October 01, 2017.
CEO of consortium management TPA provider TSS INC, Renee Schofield, says, “At a time when our nation is facing a serious public health crises in the form of opioid misuse, abuse and addiction, this is the right move by DOT to work toward solutions that not only help promote transportation safety but can save a life before it’s too late.”
The Final Rule update also requires that all employers and service agents participating in 49 CFR Part 40 drug testing join the ODAPC ListServe for pertinent industry updates and notifications. Click here for the link to join.
Quoting the TSS Inc news release, employers should make sure to update their workplace drug and alcohol policies to conform with the U.S. Department of Transportation rules, notify employees that this change will take place as of January 1st and call TSS if any other questions arise.
The DOT drug testing program has been proven effective in reducing the impact of drug and alcohol use in the workplace for over two decades and is a model for all employers on the efficacy of a drug and alcohol policy that requires responsible employee screening according to Schofield.
Editing by Mary Kauffman, SitNews
Source of News:
Representations of fact and opinions in comments posted are solely those of the individual posters and do not represent the opinions of Sitnews.